Clinical Trials Logo

Clinical Trial Summary

This study is intended to provide a basis for decision-making for the improved medical care of patients with asymptomatic heart failure, especially in structurally weak regions.


Clinical Trial Description

The aim of the study is the early detection of asymptomatic heart failure with a quality-assured cardiac screening MRI in the population in structurally weak regions and especially in patients with risk factors for the occurrence of heart failure. The diagnosis will be followed by early initiation of appropriate therapeutic measures to improve the prognosis of the affected patients, avoid hospitalisations and save therapy costs, and will be combined with recommended measures to minimise risk factors for the development of heart failure. The project includes a prospective, monocentric, randomised controlled clinical trial with blinded assessment of the endpoint (PROBE design). Within the scope of the study, 6,600 patients aged between 40 and 69 years who have characteristic risk factors for the development of heart failure will be examined using a mobile cardiac screening MRI in the federal states of Brandenburg and Mecklenburg-Western Pomerania within Germany. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05122793
Study type Interventional
Source German Heart Institute
Contact Sebastian Kelle, MD
Phone 0049 30 4593 1182
Email [email protected]
Status Recruiting
Phase N/A
Start date June 21, 2021
Completion date January 31, 2024

See also
  Status Clinical Trial Phase
Not yet recruiting NCT05030987 - Renal Denervation to Treat Heart Failure With Preserved Ejection Fraction N/A
Recruiting NCT05095688 - Relationship Between Adipose Tissue Distribution and Arterial Stiffness in HFpEF
Recruiting NCT04153136 - Effects of Sacubitril/Valsartan on Subclinical Heart Failure in HIV (The ENCHANTMENT HIV Study) Phase 2
Recruiting NCT05126836 - Cilostazol for HFpEF Phase 2
Recruiting NCT04535726 - The Relationship Between Blood Pressure and Arterial Stiffness in HFpEF Patients With Different Levels of Obesity
Recruiting NCT04594499 - The Relationship Between Pericardial Fat Thickness and Arterial Stiffness in HFpEF Patients
Recruiting NCT03550235 - Exploration of Dyspnea at Non-high Brain Natriuretic Peptide (BNP)
Recruiting NCT04633460 - Acute Effects of Exogenous Ketone Ester Administration in Heart Failure Phase 2
Completed NCT01726049 - Sildenafil in HFpEF and PH Phase 3
Completed NCT01185067 - Physiological Effects of Grape Seed Extract in Diastolic Heart Failure Phase 1
Completed NCT01091467 - Prospective Study of Heart Failure With Preserved Left Ventricular Ejection Fraction
Completed NCT05068934 - The Relationship Between Epicardial Fat Tissue and Cardiac Function in HFpEF Patients
Recruiting NCT04913805 - Matching Perfusion and Metabolic Activity in HFpEF Phase 2
Recruiting NCT05059769 - Relationship Between Ambulatory Arterial Stiffness Index and Left Ventricular Diastolic Function in Patients With HFpEF
Not yet recruiting NCT04945707 - Impact of Intravenous Iron Repletion On Mechanisms of Exercise InTolerance in HFpEF (IRONMET-HFpEF) Phase 4
Not yet recruiting NCT05053256 - The Relationship Between Heart Function and Metabolism in HFpEF Patients
Recruiting NCT04237701 - Real-Time Monitoring of Heart Failure Across the Yale New Haven Health System
Recruiting NCT05055180 - Right Ventricular Function and Pulmonary Hypertension in HFpEF
Enrolling by invitation NCT04019613 - Assessment of Pulmonary Congestion During Cardiac Hemodynamic Stress Testing N/A
Completed NCT03254485 - A Study of the Effect of IW-1973 on the Exercise Capacity of Patients With Heart Failure With Preserved Ejection Fraction (HFpEF) Phase 2